Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Drugs and Medicinal Substances

Corticorelin

Various

Corticorelin is a synthetic peptide that copies corticotropin-releasing hormone, the signal the hypothalamus sends to make the pituitary gland release adrenocorticotropic hormone (ACTH). It is used only as a diagnostic agent and is not a treatment. Marketed as Acthrel, corticorelin ovine triflutate is given as an intravenous injection, and the label describes it as a test of pituitary corticotroph responsiveness that helps tell a pituitary source of excess ACTH from an ectopic source in patients with ACTH-dependent Cushing's syndrome. A rise or absence of rise in blood ACTH and cortisol after the dose guides the interpretation. ChEMBL records it as a protein with a first approval in 1996, and its ATC code, V04CD04, places it among the diagnostic agents.

Facts
Classification
Approval Status
Approved 1
ATC Class
V: Various 2
Route of Administration
Intravenous 3
First Approved / Isolated Year
1996 1
Connections

Treats

Source DailyMed, National Library of Medicine: Acthrel (corticorelin ovine triflutate) label, DailyMed
Sources
1. Corticorelin ovine triflutate (ChEMBL record)
  • ChEMBL molecule record CHEMBL1201591, first_approval field
    "first_approval": 1996
  • ChEMBL molecule record CHEMBL1201591, max_phase 4.0 means approved
    "max_phase": "4.0"
View the Source
2. ChEMBL, EMBL-EBI: ChEMBL molecule record CHEMBL2108182 (Corticorelin)
ChEMBL, EMBL-EBIatc_classifications of the molecule record; ATC class derived from cited code V04CD04 (main group V)
Quote, atc_classifications of the molecule record; ATC class derived from cited code V04CD04 (main group V)
"atc_classifications": [ "V04CD04" ], "molecule_chembl_id": "CHEMBL2108182", "pref_name": "CORTICORELIN"
View the Source
3. DailyMed, National Library of Medicine: Acthrel (corticorelin ovine triflutate) label, DailyMed
DailyMed, National Library of Medicine
  • Label header, route statement
    For intravenous injection only
  • Treats: Cushing's Syndrome, Indications and usage; a diagnostic use, not a treatment
    ACTHREL® is indicated for use in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.